With restrictions easing, is the Cochlear (ASX:COH) share price a buy?

with restrictions easing is the cochlear asxcoh share price a buy 1

Sumary of With restrictions easing, is the Cochlear (ASX:COH) share price a buy?:

  • Tribecca Investment Partners portfolio manager Jun Bei Liu thinks so.
  • Cochlear is a global leader in implantable hearing devices, and that’s exactly why Liu believes it’s one to buy now and hold for the future.
  • It currently holds more than 60% of the hearing device market, according to Liu.
  • Liu told LiveWire another reason she thinks Cochlear shares are a buy is because the company works in an under-penetrated market – only 60,000 people receive implantable hearing devices each year.
  • Livewire quoted Liu as saying: Cochlear is the most advanced with a fully implantable device which is likely to be the next major development in the space.

Want to know more click here go to source.

From -

Generic selectors
Exact matches only
Search in title
Search in content

Site Language

By continuing to use the site, you agree to the use of cookies. more information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.